Trial intelligence / Profile preview

Pantoprazole for vomiting control in pediatric acute gastroenteritis

IRCT20241017063400N1Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Jan 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in acute gastroenteritis comparing Pantoprazole with Placebo (2 arms). Primary endpoints: Number of days of hospitalization and Duration of oral intolerance after the initiation of treatment. Started Jan 2025; status: completed.

02

Drugs

pantoprazole
03

Conditions

acute gastroenteritis

Beyond the preview

Go deeper on IRCT20241017063400N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20241017063400N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call